Wirk, Baldeep, and Jin Lim. “Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma”. Journal of Hematology, vol. 14, no. 3, June 2025, pp. 146-51, https://doi.org/10.14740/jh2046.